Financings in Brief: Cypress Bioscience
This article was originally published in The Gray Sheet
Executive Summary
Cypress Bioscience: Developer of immuno-adsorption technology will extend the expiration date of its common stock purchase warrants from Dec. 31, 1996 to April 30, 1997. The San Diego-based company issued 1.8 mil. of the warrants, which entitle holders to purchase one share of common stock for $2.50, in August 1991...